Fen Li Selected Research

Char syndrome

1/2018	Tfap2b mutation in mice results in patent ductus arteriosus and renal malformation.
5/2014	Characterization of transcription factor AP-2 β mutations involved in familial isolated patent ductus arteriosus suggests haploinsufficiency.
10/2011	Familial nonsyndromic patent ductus arteriosus caused by mutations in TFAP2B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fen Li Research Topics

Disease

31	Neoplasms (Cancer) 01/2024 - 01/2013
17	Rheumatoid Arthritis 01/2024 - 03/2006
16	Inflammation (Inflammations) 12/2023 - 01/2015
12	Nasopharyngeal Carcinoma 06/2023 - 01/2013
9	Infections 03/2024 - 01/2008
9	Squamous Cell Carcinoma of Head and Neck 01/2023 - 01/2013
8	Neoplasm Metastasis (Metastasis) 06/2023 - 06/2014
7	Allergic Rhinitis 01/2024 - 08/2020
6	Type 2 Diabetes Mellitus (MODY) 01/2024 - 12/2015
6	Carcinogenesis 06/2023 - 01/2015
6	Ankylosing Spondylitis 03/2022 - 01/2020
6	Congenital Heart Defects (Congenital Heart Defect) 01/2018 - 11/2004
5	Pulmonary Artery Stenosis 07/2023 - 11/2004
5	Insulin Resistance 01/2020 - 11/2015
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2023 - 11/2016
4	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2023 - 01/2021
4	COVID-19 07/2023 - 11/2020
4	Sepsis (Septicemia) 01/2023 - 10/2018
4	Autoimmune Diseases (Autoimmune Disease) 08/2022 - 09/2010
4	Obesity 06/2021 - 07/2007
4	Pain (Aches) 01/2021 - 05/2012
4	Patent Ductus Arteriosus 01/2018 - 04/2004
3	Breast Neoplasms (Breast Cancer) 12/2023 - 01/2013
3	Tachycardia (Tachyarrhythmias) 05/2023 - 04/2009
3	Diabetes Mellitus 01/2023 - 07/2007
3	Fibrosis (Cirrhosis) 08/2022 - 01/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2013
3	DiGeorge Syndrome (Syndrome, DiGeorge) 01/2021 - 12/2011
3	Hypoxia (Hypoxemia) 01/2021 - 06/2008
3	Myopia 01/2020 - 01/2017
3	Char syndrome 01/2018 - 10/2011
3	Tuberculosis (Tuberculoses) 08/2014 - 09/2011
3	Pathologic Constriction (Stenosis) 05/2014 - 04/2009
2	Cerebral Hemorrhage 03/2024 - 11/2018
2	Liver Diseases (Liver Disease) 01/2024 - 01/2020
2	Pneumonia (Pneumonitis) 01/2024 - 08/2018
2	Hypertrophy 12/2023 - 01/2018
2	Hemorrhage 11/2023 - 10/2023
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2023 - 01/2019
2	Hyperalgesia 07/2023 - 01/2017
2	Chronic Pain 07/2023 - 01/2017

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2015
13	Proteins (Proteins, Gene)FDA Link 12/2023 - 06/2008
6	MicroRNAs (MicroRNA)IBA 03/2023 - 01/2018
5	Glucose (Dextrose)FDA LinkGeneric 03/2024 - 07/2007
5	Insulin (Novolin)FDA Link 01/2024 - 11/2015
5	AntibodiesIBA 09/2023 - 03/2006
5	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 09/2018
5	Transcription Factors (Transcription Factor)IBA 01/2021 - 10/2011
5	Therapeutic UsesIBA 08/2020 - 04/2009
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2024 - 01/2008
4	CytokinesIBA 01/2022 - 01/2015
4	DNA (Deoxyribonucleic Acid)IBA 06/2020 - 06/2012
4	Infliximab (Remicade)FDA Link 08/2019 - 10/2010
3	EnzymesIBA 03/2024 - 09/2011
3	CalciumIBA 03/2024 - 06/2008
3	AlbuminsIBA 03/2024 - 01/2021
3	Messenger RNA (mRNA)IBA 01/2024 - 06/2008
3	ResveratrolIBA 01/2024 - 07/2010
3	LigandsIBA 12/2023 - 09/2019
3	SmokeIBA 07/2023 - 05/2010
3	Long Noncoding RNAIBA 03/2023 - 01/2021
3	Eosine Yellowish-(YS) (Eosin)IBA 01/2023 - 01/2018
3	iguratimodIBA 08/2022 - 01/2020
3	Adalimumab (Humira)FDA Link 03/2022 - 01/2020
3	Biosimilar PharmaceuticalsIBA 03/2022 - 01/2020
3	Antirheumatic Agents (DMARD)IBA 01/2022 - 01/2020
3	AutoantibodiesIBA 01/2022 - 09/2010
3	Uric Acid (Urate)IBA 01/2021 - 03/2012
3	3,3'-diindolylmethane (diindolylmethane)IBA 02/2016 - 06/2014
2	Alanine Transaminase (SGPT)IBA 03/2024 - 07/2007
2	Immunologic Factors (Immunomodulators)IBA 03/2024 - 01/2023
2	Interleukin-6 (Interleukin 6)IBA 03/2024 - 01/2008
2	Interleukin-1 (Interleukin 1)IBA 03/2024 - 01/2017
2	LipidsIBA 03/2024 - 01/2017
2	Dexmedetomidine FDA Link 03/2024 - 11/2018
2	Antihypertensive Agents (Antihypertensives)IBA 03/2024 - 11/2018
2	Remifentanil (Ultiva)FDA Link 03/2024 - 11/2018
2	Serine (L-Serine)FDA Link 01/2024 - 05/2018
2	GlucocorticoidsIBA 12/2023 - 07/2023
2	Indicators and Reagents (Reagents)IBA 12/2023 - 01/2020
2	Sirtuin 1IBA 09/2023 - 01/2022
2	ZincIBA 07/2023 - 01/2008
2	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 07/2023 - 01/2017
2	calpeptinIBA 07/2023 - 08/2018
2	Glutamic Acid (Glutamate)FDA Link 07/2023 - 01/2017
2	Protein Kinases (Protein Kinase)IBA 07/2023 - 05/2018
2	Sincalide FDA Link 06/2023 - 01/2023
2	Untranslated RNA (Noncoding RNA)IBA 01/2023 - 01/2023
2	AllergensIBA 01/2023 - 01/2015
2	Immunoglobulin E (IgE)IBA 01/2023 - 08/2020
2	Macrophage Migration-Inhibitory FactorsIBA 01/2023 - 01/2022

Therapy/Procedure

18	Therapeutics 11/2023 - 11/2004
5	Stents 11/2023 - 04/2009
4	Length of Stay 01/2021 - 12/2007
3	Radiotherapy 06/2023 - 05/2010
3	Drug Therapy (Chemotherapy) 08/2022 - 05/2010
3	Artificial Respiration (Mechanical Ventilation) 01/2022 - 12/2007
2	Spinal Injections 07/2023 - 01/2017
2	Chemoradiotherapy 06/2023 - 06/2014